Senseonics shares dip on Q4 sales miss, lowered guidance

This article was originally published here

Senseonics

Shares in Senseonics (NYSE:SENS) fell slightly today after the diabetes-focused device maker posted fourth quarter and full year 2018 earnings that beat loss-per-share consensus but missed sales expectations and lowered its guidance for the 2019 fiscal year.

The Germantown, Md.-based company posted losses of $7.3 million, or 4¢ per share, on sales of $7.2 million for the three months ended December 31, seeing losses shrink 55.2% while sales grew 148.3% compared with the same period during the previous year.

Read the whole story on our sister site, Drug Delivery Business News

The post Senseonics shares dip on Q4 sales miss, lowered guidance appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply